Right, all of those articles are referencing the fact that AMBS licensed the technology from Bascom in 2014. I was aware of that. AMBS issued a press release at the time.
Where is there any information about a trial that has been on-going for the past year. Or that one even started?
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links